Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BlueJays9293on Dec 21, 2023 7:51pm
134 Views
Post# 35796866

RE:RE:RE:RE:RE:RE:Exciting Developments Unveiled: A Deep Dive into Spectral's

RE:RE:RE:RE:RE:RE:Exciting Developments Unveiled: A Deep Dive into Spectral's Def Chester!

Love having Mayo onboard, now that's def a KOL no.

Where the rubber really is going to meet the road for Spectral shareholders is the ARR.

If MM's little wet dream of 20% ARR at the interim and thereby the final truly does happen?

Then don't take your finger off of the buy button.

That's the biggest driver of what Spectral can charge per column.

period.

If they get anything close to a 20% ARR,

well then you might as well immediately double all those numbers on slide #17.

20% ARR is freaking unheard of.

It's a true Unicorn,

with only the likes of people like Alexender Fleming as it's founfing members.


<< Previous
Bullboard Posts
Next >>